Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Siemens AG
  6. News
  7. Summary
    SIE   DE0007236101

SIEMENS AG

(SIE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Siemens : and BioNTech expand their collaboration for global vaccine production

06/23/2021 | 09:41am EDT

Press

Nuremberg, June 23, 2021

Siemens and BioNTech expand their collaboration for global vaccine production

  • Siemens supplies the latest automation and digitalization technology for the production of Covid-19 vaccines
  • Joint creation of a vaccine production facility in Singapore

German biotechnology company BioNTech SE, based in Mainz, and Siemens intend to expand their strategic cooperation. The companies plan to intensify their collaboration for the rapid expansion and creation of production capacity for the Covid-19 vaccine. BioNTech has expressed its aim of establishing new production sites for Covid-19 vaccine production worldwide based on the Marburg plant and its technology, starting with a production facility in Singapore. In Marburg, BioNTech has converted an existing plant into a vaccine production facility with support from Siemens in just five months. Within this cooperation, Siemens will provide the latest automation and digitalization technologies for BioNTech production sites, such as design, simulation, and engineering software as well as process control technology.

"Siemens and BioNTech have worked together successfully for years. BioNTech was one of the first companies together with Pfizer to bring a new mRNA vaccine to market. Our technologies and long-standing expertise have helped them to convert their production facility in just five months rather than a year. We now want to transfer this success to other production sites in order to make Covid-19 vaccines available as quickly as possible worldwide," says Cedrik Neike, Member of the Board of Siemens AG and CEO Digital Industries.

Siemens AG

Werner-von-Siemens-Straße 1

Communications

80333 Munich

Head: Judith Wiese

Germany

Reference number: HQDIPR202106226237DE

Page 1/3

Siemens AG

Press release

German biotechnology company BioNTech SE and Siemens intend to expand their strategic cooperation. The companies plan to intensify their collaboration for the rapid expansion and creation of production capacity for the Covid-19 vaccine (Image: © BioNTech SE 2020, all rights reserved).

This press release and a press picture are available at: https://sie.ag/3gOpoYl

Contact for journalists

Julia Kauppert

Phone: +49 (174) 311-8098;E-mail:julia.kauppert@siemens.com

Follow us on Social Media:

Twitter: www.twitter.com/siemens_pressand www.twitter.com/SiemensIndustry

Blog: https://ingenuity.siemens.com

Siemens Digital Industries (DI) is an innovation leader in automation and digitalization. Closely collaborating with partners and customers, DI drives the digital transformation in the process and discrete industries. With its Digital Enterprise portfolio, DI provides companies of all sizes with an end-to-end set of products, solutions and services to

Reference number: HQDIPR202106226237DE

Page 2/3

Siemens AG

Press release

integrate and digitalize the entire value chain. Optimized for the specific needs of each industry, DI's unique portfolio supports customers to achieve greater productivity and flexibility. DI is constantly adding innovations to its portfolio to integrate cutting-edge future technologies. Siemens Digital Industries has its global headquarters in Nuremberg, Germany, and has around 76,000 employees internationally.

Siemens AG (Berlin and Munich) is a technology company focused on industry, infrastructure, transport, and healthcare. From more resource-efficient factories, resilient supply chains, and smarter buildings and grids, to cleaner and more comfortable transportation as well as advanced healthcare, the company creates technology with purpose adding real value for customers. By combining the real and the digital worlds, Siemens empowers its customers to transform their industries and markets, to transform the everyday for billions of people. Siemens also owns a majority stake in the publicly listed company Siemens Healthineers, a globally leading medical technology provider shaping the future of healthcare. In addition, Siemens holds a minority stake in Siemens Energy, a global leader in the transmission and generation of electrical power.

In fiscal 2020, which ended on September 30, 2020, the Siemens Group generated revenue of €55.3 billion and net income of €4.2 billion. As of September 30, 2020, the company had around 293,000 employees worldwide. Further information is available on the Internet at www.siemens.com.

Reference number: HQDIPR202106226237DE

Page 3/3

Disclaimer

Siemens AG published this content on 23 June 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 23 June 2021 13:40:03 UTC.


ę Publicnow 2021
All news about SIEMENS AG
10:18aSIEMENS : Costain - Green light for path to UK's first 'electric motorway'
AQ
07/27SIEMENS HEALTHINEERS : JP Morgan reiterates its Buy rating
MD
07/26SIEMENS GAMESA RENEWABLE ENERGY S A : SSE To Jointly Develop Green Hydrogen In W..
MT
07/26SIEMENS GAMESA : UBS gives a Neutral rating
MD
07/26DGAP-CMS : Siemens Healthineers AG: Release of a capital market information
DJ
07/26SIEMENS GAMESA RENEWABLE ENERGY S A : SSE, Siemens Gamesa to seek green hydrogen..
RE
07/26DGAP-CMS : Siemens Aktiengesellschaft: Release of a capital market information
DJ
07/23SIEMENS : U.S. business borrowing for equipment rises 17% in June - ELFA
RE
07/23Siemens new natural extinguishing agents protect business continuity in criti..
AQ
07/22MARKET CHATTER : Swiss Life to Bid for German Biotech-Focused Industrial Park
MT
More news
Financials
Sales 2021 60 242 M 71 339 M 71 339 M
Net income 2021 5 550 M 6 573 M 6 573 M
Net Debt 2021 32 953 M 39 023 M 39 023 M
P/E ratio 2021 19,5x
Yield 2021 2,66%
Capitalization 106 B 126 B 126 B
EV / Sales 2021 2,31x
EV / Sales 2022 2,15x
Nbr of Employees 293 000
Free-Float 88,0%
Chart SIEMENS AG
Duration : Period :
Siemens AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SIEMENS AG
Short TermMid-TermLong Term
TrendsNeutralBearishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 24
Last Close Price 133,24 €
Average target price 160,43 €
Spread / Average Target 20,4%
EPS Revisions
Managers and Directors
Roland Emil Busch President & Chief Executive Officer
Ralf Peter Thomas Chief Financial Officer
Jim Hagemann Snabe Chairman-Supervisory Board
Hanna Hennig Chief Information Officer
Andreas Christian Hoffmann General Counsel, Head-Legal & Compliance
Sector and Competitors
1st jan.Capi. (M$)
SIEMENS AG13.36%125 961
BERKSHIRE HATHAWAY INC.21.42%641 892
HONEYWELL INTERNATIONAL INC.8.30%159 040
3M COMPANY14.69%116 000
GENERAL ELECTRIC COMPANY21.11%114 859
ILLINOIS TOOL WORKS INC.11.70%71 936